Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis Academic Article Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Pathology, Molecular
  • Receptor Protein-Tyrosine Kinases

abstract

  • Two courses of postorchiectomy adjuvant chemotherapy were safe and well tolerated and markedly decreased the relapse rate in high-risk patients with clinical Stage I nonseminomatous germ cell testicular tumor without additional surgery or more protracted chemotherapy. This approach may avoid potential problems with compliance and diminish the cost of scrupulous follow-up. Our results support that surveillance for carefully selected patients at a low risk of relapse is appropriate.

publication date

  • January 2004

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.urology.2003.08.045

PubMed ID

  • 14751368

Additional Document Info

start page

  • 144

end page

  • 8; discussion 148-9

volume

  • 63

number

  • 1